CTRI/2023/07/055057尚未招募3 期
An Open Label, Prospective, Non-Comparative, Single Arm Clinical Study to Evaluate the Efficacy, Safety and Tolerability of H-Vit Hair Serum of Systopic Laboratories Pvt. Ltd. in Hair Fall Control, Hair Growth Potential and Improvement in Hair Health in Adult Volunteers - NI
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Clinically healthy adult subjects between the ages of 21 and 55 years both ages and all genders inclusive looking to improve their hair health.
- •2. Subjects who agree not to dye or colour, cut or trim, straightening or other cosmetic treatments and or under go any hair treatments not limited to hair spa at beauty saloons or parlours for the duration of participation in the clinical study.
- •3. Subjects with complaints of non associated excessive hair fall, brittle or thin hair, dry or damaged hair.
- •4. Subjects who are willing to abstain from the use of any dedicated products not limited to hair oil, shampoo, conditioner, hair mask, hair serum, hair treatments and remedies to improve hair fall and other hair health parameters.
- •5. Subjects who are willing to abstain from the use of any oral or tropical medications not limited to collagen, biotin supplements indicated and improving hair fall and other hair health parameters.
- •6. Subjects who are willing to give informed consent for participation, able to comprehend ad understand the responsibilities during screening and treatment period
- •7. Subjects who are willing not to participate in any other clinical trial during participation in the current trial.
排除标准
- •1. Subjects with known hypersensitivity to the ingredients of the investigational product.
- •2. Subjects who have had an active trichological procedure done upto 3 months prior to screening
- •Subjects who have dyed their hair upto 30 days prior to screening
- •3. Subjects who have scalp conditions not limited to seborrheic dermatitis, psoriasis, alopecia areata, significant scalp scarring that prevents proper examination or evaluation of study criteria.
- •4. Subjects with Trichotillomania
- •5. Subjects who have anemia or iron deficiency.
- •6. Subjects who have previously undergone hair transplantation procedures.
- •7. Subjects who have an active infection, disease or disorder that will prevent them from fully satisfying their responsibilities of the study.
- •8. Subjects with history of seizures, uncontrolled diabetes, hypertension or major cardiac illness like congestive heart failure etc.
- •9. Subjects suffering from, on remission from cancer of any type less than 5 years at the time of screening.
- •10. Subjects who are planning a pregnancy and, or currently breastfeeding
- •11. Subjects who have participated in a clinical trial less than 1 month before screening.
- •12. Any significant medical condition e.g., significant psychiatric or neurological disorders, active alcohol or drug abuse etc., any medical condition that unstable, poorly controlled or other factor e.g., planned relocation that the investigator felt would interfere with study evaluations and study participation.
- •13. Subjects who mentally unable to comprehend the responsibilities and adhere to the stipulations of the protocol
- •14. Subjects who in the opinion of the investigator are not eligible for enrolment in the study
研究者
相似试验
已完成
3 期
Clinical Study on Stonvil Capsule to treat Kidney StoneCTRI/2019/04/018423SG Phyto Pharma Pvt Ltd46
招募中
不适用
Clinical Study on D-Frag Tablets for improving Sperm Quality (Sperm DNA)CTRI/2018/10/016090utri Synapzz Therapeutix Private Limited
已完成
1 期
Pilot Clinical Study on â??Sorajit Capsulesâ?? of SG Phyto Pharma Pvt. Ltd. to treat Chronic Plaque PsoriasisCTRI/2022/03/041024SG Phyto Pharma Pvt Ltd26
已完成
4 期
Ophthalmological and Dermatological Safety Study to Determine Possible Benefits of Dheedhi Herbal Kajal.CTRI/2013/10/004093Dhathri Ayurveda Private Limited24
已完成
3 期
Clinical Study on Boostex Forte to Treat for Erectile Dysfunction and Premature Ejaculation.CTRI/2021/02/031190SG Phyto Pharma Private Limited80
